Cargando…
Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies
Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been related to the risk of cardiovascular disorders. However, the association between circulating TMAO and the risk of cardiovascular events has not been quantitatively evaluated. We performed a systematic review...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742728/ https://www.ncbi.nlm.nih.gov/pubmed/28782886 http://dx.doi.org/10.1111/jcmm.13307 |
_version_ | 1783288436909670400 |
---|---|
author | Qi, Jiaqian You, Tao Li, Jing Pan, Tingting Xiang, Li Han, Yue Zhu, Li |
author_facet | Qi, Jiaqian You, Tao Li, Jing Pan, Tingting Xiang, Li Han, Yue Zhu, Li |
author_sort | Qi, Jiaqian |
collection | PubMed |
description | Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been related to the risk of cardiovascular disorders. However, the association between circulating TMAO and the risk of cardiovascular events has not been quantitatively evaluated. We performed a systematic review and meta‐analysis of all available cohort studies regarding the association between baseline circulating TMAO and subsequent cardiovascular events. Embase and PubMed databases were searched for relevant cohort studies. The overall hazard ratios for the developing of cardiovascular events (CVEs) and mortality were extracted. Heterogeneity among the included studies was evaluated with Cochran's Q Test and I (2) statistics. A random‐effect model or a fixed‐effect model was applied depending on the heterogeneity. Subgroup analysis and meta‐regression were used to evaluate the source of heterogeneity. Among the 11 eligible studies, three reported both CVE and mortality outcome, one reported only CVEs and the other seven provided mortality data only. Higher circulating TMAO was associated with a 23% higher risk of CVEs (HR = 1.23, 95% CI: 1.07–1.42, I (2) = 31.4%) and a 55% higher risk of all‐cause mortality (HR = 1.55, 95% CI: 1.19–2.02, I (2) = 80.8%). Notably, the latter association may be blunted by potential publication bias, although sensitivity analysis by omitting one study at a time did not significantly change the results. Further subgroup analysis and meta‐regression did not support that the location of the study, follow‐up duration, publication year, population characteristics or the samples of TMAO affect the results significantly. Higher circulating TMAO may independently predict the risk of subsequent cardiovascular events and mortality. |
format | Online Article Text |
id | pubmed-5742728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57427282018-01-04 Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies Qi, Jiaqian You, Tao Li, Jing Pan, Tingting Xiang, Li Han, Yue Zhu, Li J Cell Mol Med Original Articles Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been related to the risk of cardiovascular disorders. However, the association between circulating TMAO and the risk of cardiovascular events has not been quantitatively evaluated. We performed a systematic review and meta‐analysis of all available cohort studies regarding the association between baseline circulating TMAO and subsequent cardiovascular events. Embase and PubMed databases were searched for relevant cohort studies. The overall hazard ratios for the developing of cardiovascular events (CVEs) and mortality were extracted. Heterogeneity among the included studies was evaluated with Cochran's Q Test and I (2) statistics. A random‐effect model or a fixed‐effect model was applied depending on the heterogeneity. Subgroup analysis and meta‐regression were used to evaluate the source of heterogeneity. Among the 11 eligible studies, three reported both CVE and mortality outcome, one reported only CVEs and the other seven provided mortality data only. Higher circulating TMAO was associated with a 23% higher risk of CVEs (HR = 1.23, 95% CI: 1.07–1.42, I (2) = 31.4%) and a 55% higher risk of all‐cause mortality (HR = 1.55, 95% CI: 1.19–2.02, I (2) = 80.8%). Notably, the latter association may be blunted by potential publication bias, although sensitivity analysis by omitting one study at a time did not significantly change the results. Further subgroup analysis and meta‐regression did not support that the location of the study, follow‐up duration, publication year, population characteristics or the samples of TMAO affect the results significantly. Higher circulating TMAO may independently predict the risk of subsequent cardiovascular events and mortality. John Wiley and Sons Inc. 2017-08-07 2018-01 /pmc/articles/PMC5742728/ /pubmed/28782886 http://dx.doi.org/10.1111/jcmm.13307 Text en © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Qi, Jiaqian You, Tao Li, Jing Pan, Tingting Xiang, Li Han, Yue Zhu, Li Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title | Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title_full | Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title_fullStr | Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title_full_unstemmed | Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title_short | Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
title_sort | circulating trimethylamine n‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742728/ https://www.ncbi.nlm.nih.gov/pubmed/28782886 http://dx.doi.org/10.1111/jcmm.13307 |
work_keys_str_mv | AT qijiaqian circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT youtao circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT lijing circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT pantingting circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT xiangli circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT hanyue circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies AT zhuli circulatingtrimethylaminenoxideandtheriskofcardiovasculardiseasesasystematicreviewandmetaanalysisof11prospectivecohortstudies |